1. Home
  2. GRFS vs HLNE Comparison

GRFS vs HLNE Comparison

Compare GRFS & HLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • HLNE
  • Stock Information
  • Founded
  • GRFS 1940
  • HLNE 1991
  • Country
  • GRFS Spain
  • HLNE United States
  • Employees
  • GRFS N/A
  • HLNE N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • HLNE Investment Managers
  • Sector
  • GRFS Health Care
  • HLNE Finance
  • Exchange
  • GRFS Nasdaq
  • HLNE Nasdaq
  • Market Cap
  • GRFS 6.2B
  • HLNE 5.9B
  • IPO Year
  • GRFS 2006
  • HLNE 2017
  • Fundamental
  • Price
  • GRFS $10.10
  • HLNE $156.86
  • Analyst Decision
  • GRFS Hold
  • HLNE Hold
  • Analyst Count
  • GRFS 1
  • HLNE 7
  • Target Price
  • GRFS $10.30
  • HLNE $158.57
  • AVG Volume (30 Days)
  • GRFS 1.1M
  • HLNE 720.4K
  • Earning Date
  • GRFS 01-01-0001
  • HLNE 08-05-2025
  • Dividend Yield
  • GRFS N/A
  • HLNE 1.38%
  • EPS Growth
  • GRFS N/A
  • HLNE 46.35
  • EPS
  • GRFS 0.31
  • HLNE 5.41
  • Revenue
  • GRFS $7,968,532,207.00
  • HLNE $712,963,000.00
  • Revenue This Year
  • GRFS $7.14
  • HLNE $0.09
  • Revenue Next Year
  • GRFS $7.16
  • HLNE $18.35
  • P/E Ratio
  • GRFS $41.40
  • HLNE $29.01
  • Revenue Growth
  • GRFS 10.76
  • HLNE 28.73
  • 52 Week Low
  • GRFS $6.19
  • HLNE $123.98
  • 52 Week High
  • GRFS $10.30
  • HLNE $203.72
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 67.23
  • HLNE 58.84
  • Support Level
  • GRFS $9.66
  • HLNE $150.06
  • Resistance Level
  • GRFS $10.30
  • HLNE $160.35
  • Average True Range (ATR)
  • GRFS 0.26
  • HLNE 4.34
  • MACD
  • GRFS 0.00
  • HLNE 0.98
  • Stochastic Oscillator
  • GRFS 85.19
  • HLNE 77.08

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About HLNE Hamilton Lane Incorporated

Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.

Share on Social Networks: